Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last for a ...
MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...
In the phase 3 study, QWINT-1, efsitora was administered via four fixed doses once weekly in a single-use autoinjector in people with type 2 diabetes using basal insulin for the first time In a second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback